DE69616803D1 - Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren - Google Patents

Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren

Info

Publication number
DE69616803D1
DE69616803D1 DE69616803T DE69616803T DE69616803D1 DE 69616803 D1 DE69616803 D1 DE 69616803D1 DE 69616803 T DE69616803 T DE 69616803T DE 69616803 T DE69616803 T DE 69616803T DE 69616803 D1 DE69616803 D1 DE 69616803D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
composition containing
interferon gamma
containing interferon
gamma inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69616803T
Other languages
English (en)
Other versions
DE69616803T2 (de
Inventor
William Ferguson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of DE69616803D1 publication Critical patent/DE69616803D1/de
Application granted granted Critical
Publication of DE69616803T2 publication Critical patent/DE69616803T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE69616803T 1995-08-18 1996-08-09 Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren Expired - Lifetime DE69616803T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9516967A GB2304342A (en) 1995-08-18 1995-08-18 Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
PCT/GB1996/001949 WO1997007136A2 (en) 1995-08-18 1996-08-09 Pharmaceutical composition containing inhibitors of interferon-gamma

Publications (2)

Publication Number Publication Date
DE69616803D1 true DE69616803D1 (de) 2001-12-13
DE69616803T2 DE69616803T2 (de) 2002-06-20

Family

ID=10779448

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69626050T Expired - Lifetime DE69626050T2 (de) 1995-08-18 1996-08-09 Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
DE69616803T Expired - Lifetime DE69616803T2 (de) 1995-08-18 1996-08-09 Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69626050T Expired - Lifetime DE69626050T2 (de) 1995-08-18 1996-08-09 Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren

Country Status (13)

Country Link
EP (2) EP0845007B1 (de)
JP (2) JP4070809B2 (de)
AT (2) ATE231728T1 (de)
AU (1) AU713809B2 (de)
CA (1) CA2229590C (de)
DE (2) DE69626050T2 (de)
DK (2) DK0972521T3 (de)
ES (2) ES2192018T3 (de)
GB (1) GB2304342A (de)
HK (1) HK1023516A1 (de)
PT (2) PT972521E (de)
WO (1) WO1997007136A2 (de)
ZA (1) ZA966953B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
ES2251248T3 (es) 1998-12-09 2006-04-16 Protein Design Labs, Inc. Uso de anticuerpos contra il-12 para tratar la psoriasis.
US6710025B1 (en) 1999-05-26 2004-03-23 The Brigham And Women's Hospital, Inc. Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin
JP2003500113A (ja) * 1999-05-26 2003-01-07 ザ ブリガム アンド ウイミンズ ホスピタル、 インコーポレイテッド アルファ平滑筋アクチン活性を調節する薬剤の治療的使用
US10080779B2 (en) 2004-12-15 2018-09-25 Universite D'angers Method for increasing the expression of anti-microbial peptides by keratinocytes comprising administering a composition comprising IL-17, TNF-alpha and OSM
JP5530635B2 (ja) * 2007-02-14 2014-06-25 独立行政法人科学技術振興機構 腸管癒着抑制剤
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
RU2539383C1 (ru) * 2013-11-29 2015-01-20 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Фармацевтическая композиция для лечения трофических язв и длительно незаживающих ран различной этиологии в виде мази

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78444A (en) * 1986-04-08 1992-05-25 Yeda Res & Dev Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody
EP0311616B1 (de) * 1986-06-17 1991-09-25 Biogen, Inc. Kombination von gammainterferonen und antientzündungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten
NL8700927A (nl) * 1987-04-16 1988-11-16 Stichting Rega V Z W Anti-interferon-gamma-antilichamen; en hun therapeutische toepassing.
CA1335792C (en) * 1987-08-18 1995-06-06 Chaim O. Jacob Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
AU2855189A (en) * 1988-01-25 1989-07-27 Baker Cummins Dermatologicals, Inc. Method of treating fibrotic disorders
IL88378A (en) * 1988-11-14 2000-11-21 Yeda Res & Dev Human interferon-gamma binding proteins their manufacture and pharmaceutical compositions comprising them
SG43205A1 (en) * 1988-12-19 1997-10-17 American Cyanamid Co A method for the treatment of endotoxic shock in a mammal
GB8905400D0 (en) * 1989-03-09 1989-04-19 Jonker Margreet Medicaments
ATE132191T1 (de) * 1989-04-19 1996-01-15 Hoffmann La Roche Auflösbare interferon-gamma-rezeptoren sowie verfahren zu deren herstellung
IT1231727B (it) * 1989-08-11 1991-12-21 Enrico Savoldi Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
ZA917669B (en) * 1990-09-27 1992-08-26 Schering Corp Antagonists of human gamma interferon
WO1992014480A1 (en) * 1991-02-22 1992-09-03 Amgen Inc. Use of gm-csf and g-csf to promote accelerated wound healing
NL9101290A (nl) * 1991-07-23 1993-02-16 Stichting Rega V Z W Recombinant dna-molecuul voor de expressie van een fv-fragment van een antilichaam.
DE4234380A1 (de) * 1992-10-06 1994-04-07 Schering Ag Verwendung von Dopaminagonisten zur Aktivierung des gamma-Interferon-Produktion
JPH07508763A (ja) * 1992-11-20 1995-09-28 シェリング・コーポレーション ヒトγインターフェロンのアンタゴニスト
ES2126094T3 (es) * 1992-12-29 1999-03-16 Genentech Inc Tratamiento de la enfermedad inflamatoria de los intestinos con inhibidores del interferon-gamma.
CA2177471A1 (en) * 1993-12-09 1995-06-15 Michel Aguet Ifn-.gamma.receptor .beta.-chain and derivatives thereof

Also Published As

Publication number Publication date
AU6707196A (en) 1997-03-12
EP0972521B1 (de) 2003-01-29
EP0972521A1 (de) 2000-01-19
JP4616291B2 (ja) 2011-01-19
AU713809B2 (en) 1999-12-09
CA2229590C (en) 2010-10-12
DE69626050T2 (de) 2004-01-22
ATE231728T1 (de) 2003-02-15
EP0845007A2 (de) 1998-06-03
ZA966953B (en) 1998-02-16
CA2229590A1 (en) 1997-02-27
ES2192018T3 (es) 2003-09-16
PT845007E (pt) 2002-03-28
PT972521E (pt) 2003-06-30
DE69626050D1 (de) 2003-03-06
DK0845007T3 (da) 2001-12-17
ATE208402T1 (de) 2001-11-15
DK0972521T3 (da) 2003-05-05
HK1023516A1 (en) 2000-09-15
WO1997007136A3 (en) 1997-08-21
EP0845007B1 (de) 2001-11-07
GB2304342A (en) 1997-03-19
GB9516967D0 (en) 1995-10-18
WO1997007136A2 (en) 1997-02-27
JP4070809B2 (ja) 2008-04-02
JPH11511160A (ja) 1999-09-28
JP2007119497A (ja) 2007-05-17
DE69616803T2 (de) 2002-06-20
ES2164911T3 (es) 2002-03-01

Similar Documents

Publication Publication Date Title
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ES2130574T3 (es) Agentes de restriccion de las citoquinas.
DE69832715D1 (de) Cyclin-abhängige-kinase inhibierende purinderivate
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
ES2193919T3 (es) Inhibidores de la enzima convertidora de endotelina.
DE69414841D1 (de) Gamma - Interferon enthaltende stabile wässrige Zusammensetzung
IT8467840A1 (it) Composto e composizione farmaceutica per il trattamento della osteoporosi.
DE69616803D1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
DK267584D0 (da) Farmaceutisk praeparat til inhibering af tumorcellevaekst
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
MX9203374A (es) Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.
EP0578643A4 (de) Verbindung und pharmazeutische zusammensetzung zur behandlung von kalziumoxalatstein-krankheit.
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
IT9048526A0 (it) Composizione adesiva stabilizzante anidra per protesi dentarie.
ITMI931369A0 (it) Composizione farmaceutica per la terapia e la profilassi tumorale
ITMI931356A0 (it) Composizione farmaceutica per la terapia di sindromi di deficienza immunitaria
DE59405654D1 (de) T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen
ITMI911343A1 (it) Composizioni farmaceutiche per il trattamento di dermatosi
NO951037D0 (no) Ozonvennlig steriliseringsblanding
DK1260222T3 (da) Farmaceutiske præparater indeholdende hidtil ukendte iso-butenyl-substituerede taxaner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition